BARROW ROBERT (Chief Executive Officer) sold 2.6% of their position (29.21K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.32M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/26/2026ACC: 0001193125-26-285562
DirectorOfficer· Chief Executive Officer
Since Jan 2022
-29.21K
Net shares
Net seller
$1.32M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
29.21K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−29.21K
Price / share
$45.03
Trade value
$1.32M
% of position
2.6%
6/25/2026
1.13M→1.10M
Total
Net shares
−29.21K
Net value
-$1.32M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/25/2026 | S · Sale | −29.21K | $45.03 | $1.32M | 2.6% | 1.13M | 1.10M |
| Total | −29.21K | -$1.32M | ||||||
Derivative Transactions0
No derivative transactions reported